Patents for A61P 33 - Antiparasitic agents (21,787)
12/2008
12/04/2008WO2008145281A2 Formulations containing triazinones and iron
12/04/2008WO2008145074A2 Amino acid and nucleic acid sequences and vaccine to control ectoparasite infestations in fish
12/04/2008WO2008144924A1 Immunogenic compositions comprising an agent capable of modulating a cd 1d-modulated pathway and methods of use
12/04/2008WO2008144888A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008WO2008127381A3 Artemisinin derivatives
12/04/2008US20080300216 Dutpase Inhibitors
12/04/2008US20080299143 Cryptosporidium parvum antigens, antibodies thereof and diagnostic and therapeutic compositions thereof
12/04/2008US20080299114 Humaneered anti-factor b antibody
12/04/2008US20080299073 Method For Treatment Or Prophylaxis Of An Infection Using Either An Antibody Which Binds To IL-9 Or An Agent Which Stimulates Production Of Autoantibodies To Interleukin-9
12/04/2008DE102007025908A1 Formulierungen enthaltend Triazinone und Eisen Formulations containing triazinones and iron
12/04/2008CA2688613A1 Formulations containing triazinones and iron
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688587A1 Nucleic acid and amino acid sequences, and vaccine to control sea lice infestations in fish
12/04/2008CA2688036A1 Formulations for the oral administration of therapeutic agents and related methods
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008CN101316824A Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests
12/03/2008CN101313977A Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
12/03/2008CN100439375C Method of purifying moxidectin through crystallization
12/03/2008CN100438879C New process for making animal medicine madumycin ammonium, ivermection or dikezhuli premixed agent
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008CA2335485C Oregano for the treatment of internal parasites and protozoa
11/2008
11/27/2008WO2008144275A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/27/2008WO2008050140A3 Compounds for treatment of parasitic infection
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008CA2684764A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
11/26/2008EP1994938A1 New lipoglycodepsipeptide compositions
11/26/2008CN101312727A Anti-worm formulation
11/26/2008CN101312657A Additive for animal feed
11/26/2008CN101310720A Preparation method of artemether drop pills for treating malaria
11/26/2008CN101310709A Preparation method of dihydroartemisinin drop pills for treating malaria
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2221418C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
11/20/2008WO2008139053A1 Multilayer spheroids with anti-malaria action and with an artesunate-containing layer
11/20/2008WO2008064181A3 Prime boost canine leishmania vaccine
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287511 Anthelmintic Imidazol-Thiazole Derivates
11/20/2008US20080287433 derivatives of artemisinin, and their uses in the treatment of malaria
11/20/2008US20080287360 Administering an isolated peptide; variants, derivatives or structural equivalents of cupredoxins or cytochrome
11/20/2008US20080286817 Novel allergens and treatment
11/20/2008US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients
11/20/2008US20080286343 Solid form
11/19/2008EP1991215A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
11/19/2008EP1786434A4 Insecticidal compositions
11/19/2008CN101309918A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306113A External drug for treating scabies
11/19/2008CN101306107A Chinese traditional medicine composition for preventing and treating intestinal parasitical diseases of aquatic animal>
11/19/2008CN101306106A Compound Melia tosendan tangerine peel powder for preventing and treating intestinal parasitical diseases of aquatic animal
11/19/2008CN101305993A Composition for preventing poutry from being infected by coccidium and method thereof for preventing the coccidium infection
11/18/2008US7452963 From 7 to 50 amino acids comprising: (1) a lysine residue six to ten residues from a second lysine residue; (2) a histidine residue; and (3) at least 6% lysine residues
11/18/2008US7452915 Antiparasitic artemisinin derivatives (endoperoxides)
11/18/2008US7452900 Esters in position 20 of camptothecins
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008CA2411966C Compositions for treating or preventing malaria and method of treating malaria
11/18/2008CA2340912C Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
11/13/2008WO2008137699A2 Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
11/13/2008WO2008136791A1 Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008135442A1 Heterocyclic compounds and their use as pesticides
11/13/2008WO2008135232A1 Use and compositions of purine derivatives for the treatment of proliferative disorders
11/13/2008US20080280368 Parasitic helminth cuticlin proteins and uses thereof
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279917 Bisbenzamidines for the Treatment of Pneumonia
11/13/2008US20080279881 Modified obligate parasite polypeptide for use in treatment and prevention of scrub typhus infection
11/13/2008US20080279812 Disease Prevention and Vaccination Prior to Thymic Reactivation
11/13/2008CA2686336A1 Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
11/13/2008CA2684926A1 Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
11/13/2008CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008CA2683821A1 Heterocyclic compounds and their use as pesticides
11/12/2008EP1989200A2 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/12/2008EP1204421B1 Stress protein-peptide complexes as vaccines against intra-cellular pathogens
11/12/2008CN101302524A Fusion gene of Toxoplasma gondii multi-epitope gene and cholera toxin CTXA2/B subunit and use thereof
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302201A Nitroimidazole derivate for therapy
11/12/2008CN101301415A External-use medicament for treating pubic phthiriasis
11/12/2008CN101301288A Aquatic livestock helminth pesticides
11/12/2008CN101301280A Sustained release tablet products used as helminthic of livestock
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449545 Antimicrobial bolisin peptides
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones
11/06/2008WO2008134692A1 Aliphatic acid-containing n-halogenated amino acid formulations
11/06/2008WO2008072053A3 Substituted arylpyrazoles
11/06/2008US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
11/06/2008US20080275107 Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275035 Nitroimidazole Compounds
11/06/2008US20080274893 Spirocyclic 3-Phenyl-3substituted-4-Ketolactams and-lactones
11/06/2008US20080274095 Using antiprotozoal fusion to target and destroy cryptosporidium contaminants in health care, agriculture and food processing environments
11/06/2008CA2684101A1 Aliphatic acid-containing n-halogenated amino acid formulations
11/05/2008EP1987055A1 Novel antimicrobial peptides and use thereof
11/05/2008EP1551390A4 Levamisole, avermectins or similar in pyrrolidone solvent
11/05/2008EP1196193B1 Interleukin-1 mutein useful as vaccine adjuvant
11/05/2008CN101298615A Novel anti-plasmodium falciparum epitope and vaccine containing the same
11/05/2008CN101297967A Novel use of staphylococcus enterotoxin A gene
11/05/2008CN101297941A Combined Chinese and western medicine sustained-release agent for preventing and treating rabbit coccidiosis and preparation method thereof
11/05/2008CN101297870A Uses of Macleaya cordata total alkaloids or salts thereof for resisting liver fibrosis due to schistosomiasis
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 218